Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Visine lubricant eye drops
- Development stage
- Unknown
- Lead developer
- Kenvue
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Visine lubricant eye drops is a multi-ingredient topical ophthalmic solution developed by Johnson & Johnson for the relief of dry eye symptoms. The formulation features the **HydroBlend™** triple-lubricant system, consisting of glycerin (0.2%), hypromellose (0.36%), and polyethylene glycol 400 (1%), which work synergistically to supplement the natural tear film and provide long-lasting moisture to the ocular surface. Additionally, the product incorporates **GentlePur™** (polyquaternium-42) as a preservative, offering a safer and less irritating alternative to benzalkonium chloride (BAK), particularly for patients requiring frequent application. Clinical studies have demonstrated that the formulation is safe, comfortable, and effective in improving corneal staining scores and maintaining visual acuity in both healthy individuals and those with dry eye disease.
- Brand names
- Visine lubricant eye dropsVisine
- Other names
- HydroblendGentlePur
Beyond the preview
Go deeper on Visine lubricant eye drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Visine lubricant eye drops.